Gofen & Glossberg’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,720
Closed -$585K 476
2014
Q4
$585K Buy
5,720
+9
+0.2% +$863 0.03% 262
2014
Q3
$494K Sell
5,711
-50
-0.9% -$4.43K 0.02% 271
2014
Q2
$519K Sell
5,761
-70
-1% -$5.24K 0.02% 264
2014
Q1
$420K Hold
5,831
0.02% 283
2013
Q4
$397K Buy
5,831
+82
+1% +$5.33K 0.02% 294
2013
Q3
$350K Sell
5,749
-705
-11% -$43K 0.02% 299
2013
Q2
$360K Buy
+6,454
New +$373K 0.02% 281

Gofen & Glossberg's COV Position: Q1 2015 in Review

Gofen & Glossberg sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 5,720 shares — an estimated $585K sold.

Gofen & Glossberg first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $585K in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Gofen & Glossberg reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Gofen & Glossberg sold 5,720 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $585K.
  • Gofen & Glossberg first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Gofen & Glossberg's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $585K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Gofen & Glossberg's 13F filing for Q1 2015, filed 15 Apr 2015.